摘要
目的探讨急性心肌梗死PCI术前应用盐酸替罗非斑安全性。方法选本院102例急性心肌梗死行急诊PCI术前应用盐酸替罗非斑的病人,与98例术前不给盐酸替罗非斑仅行急诊PCI术作为对照组。术前均嚼服用阿司匹林片300mg;硫酸氢氯吡格雷片600mg;两组患者观察术中复流及出血事件。结果用盐酸替罗非斑的血管闭塞的较对照组明显少。结论早期应用盐酸替罗非斑可以改善复流,同时也增加出血事件,出血事件与用量有关。
Objective To investigate the acute myocardial infarction before the application of PCI Tirof iban Hydrochloride spot security.Methods 102 cases of hospital acute myocardial infarction before the application of emergency PCI Tirofiban Hydrochloride plaques of patients,78 cases with no preoperative Tirofi ban Hydrochloride spot emergent PCI patients only as a control group.Preoperative chewing aspirin tablets are 300mg;clopidogrel bisulfate tablets 600mg;were observed in patients with intraoperative flow and bleeding events.Conclusion Early Tirof iban Hydrochloride applications can improve the flow pattern,but also increased bleeding events,bleeding events have great relations with the dosage.
出处
《当代医学》
2010年第26期151-152,共2页
Contemporary Medicine
关键词
急性心肌梗死
出血事件
TIMIN
急诊PCI
Acute myocardial infarction
creatine phosphate kinase
troponin T
emergency PCI
